Strategikon Pharma Announces Close of Series A Financing
News provided by
Share this article
Share this article
SAN FRANCISCO, April 22, 2021 /PRNewswire/ Strategikon Pharma, a leader in digital business technology to accelerate planning, budgeting, and outsourcing for clinical trials, announced the closing of Series A financing. The round was led by Osage Venture Partners in partnership with Wing Venture Capital and Bascom Ventures. These firms add to previous high caliber investors including Life Science Angels, Band of Angels, Tech Coast Angels, Golden Seeds and Saratoga Ventures, Inc.
As the organization continues to grow, the new capital will be used to increase Strategikon s global footprint in Europe and Asia, develop new and enhance existing applications in the company s flagship Clinical Maestro™ ecosystem, and expand the breadth and depth of professional services to provide best-in-class customer experience and support.
Strategikon Pharma Announces New Software Release of Clinical Maestro - Pharmaceutical Business review
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
Sponsors Create Proposals Requests Faster with Clinical Maestro - Pharmaceutical Business review
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.